Fully engaging the T-cell receptor to transform the treatment of solid tumors
Engineered T-cell receptor complex
Driving progress across multiple technologies and solid tumor types
TCR2 researcher at the lab bench
Changing what it means to be diagnosed with solid tumors
TCR2 is now part of Adaptimmune. Link here for more information about this strategic combination.
